stars 1 stars 2 stars 3

BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) represents European small and medium-sized biotech companies involved in developing innovative products to tackle antimicrobial resistance, including preventative and curating therapies, and diagnostic tests. BEAM gives its members a unique voice to propose and support policies and incentives in antimicrobial research and development in Europe. BEAM recommends bold incentives that warrant action by policymakers to stimulate much needed innovation.

BEAM Alliance Questions

The BEAM Alliance annual revenue was $3 million in 2026.

Frederic Peyrane is the Managing Director of BEAM Alliance.

1 people are employed at BEAM Alliance.

BEAM Alliance is based in Lyon, Auvergne-Rhône-Alpes.

The NAICS codes for BEAM Alliance are [325, 32].

The SIC codes for BEAM Alliance are [283, 28].

Top BEAM Alliance Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users